Mesenchymal-stem-cell-based experimental and clinical trials: current status and open questions (Q37859370)

24 August 2017

1 reference

title

Mesenchymal-stem-cell-based experimental and clinical trials: current status and open questions (English)

1 reference

24 August 2017

mesenchymal stem cell

1 reference

Jin Wang

1

1 reference

24 August 2017

Lianming Liao

series ordinal

2

1 reference

24 August 2017

Jianming Tan

series ordinal

3

1 reference

24 August 2017

language of work or name

English

0 references

publication date

30 March 2011

1 reference

Expert Opinion on Biological Therapy

24 August 2017

1 reference

24 August 2017

11

1 reference

24 August 2017

893-909

1 reference

24 August 2017

7

1 reference

Multilineage potential of adult human mesenchymal stem cells

24 August 2017

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2011.574119

Mesenchymal stem cells reside in virtually all post-natal organs and tissues

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2011.574119

Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2011.574119

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2011.574119

Direct transdifferentiation: can cells change their phenotype without dividing?

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2011.574119

Adult bone marrow stromal cells differentiate into neural cells in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2011.574119

3D PLGA scaffolds improve differentiation and function of bone marrow mesenchymal stem cell-derived hepatocytes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2011.574119

Islet-like clusters derived from mesenchymal stem cells in Wharton's Jelly of the human umbilical cord for transplantation to control type 1 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2011.574119

In vitro differentiation of human mesenchymal stem cells to epithelial lineage

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2011.574119

Mesenchymal stem cells are recruited into wounded skin and contribute to wound repair by transdifferentiation into multiple skin cell type.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2011.574119

Small-diameter human vessel wall engineered from bone marrow-derived mesenchymal stem cells (hMSCs).

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2011.574119

Administered mesenchymal stem cells enhance recovery from ischemia/reperfusion-induced acute renal failure in rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2011.574119

Marrow-derived stromal cells express genes encoding a broad spectrum of arteriogenic cytokines and promote in vitro and in vivo arteriogenesis through paracrine mechanisms.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2011.574119

Secretion of angiogenic and antiapoptotic factors by human adipose stromal cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2011.574119

Paracrine factors of mesenchymal stem cells recruit macrophages and endothelial lineage cells and enhance wound healing

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2011.574119

Cytokines produced by bone marrow cells can contribute to functional improvement of the infarcted heart by protecting cardiomyocytes from ischemic injury.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2011.574119

Immunomodulatory properties of mesenchymal stromal cells and their therapeutic consequences for immune-mediated disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2011.574119

Mesenchymal stem cells in health and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2011.574119

Human mesenchymal stem cells modulate allogeneic immune cell responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2011.574119

Soluble mediators from mesenchymal stem cells suppress T cell proliferation by inducing IL-10.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2011.574119

Human leukocyte antigen-G5 secretion by human mesenchymal stem cells is required to suppress T lymphocyte and natural killer function and to induce CD4+CD25highFOXP3+ regulatory T cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2011.574119

Human bone marrow stromal cells suppress T-lymphocyte proliferation induced by cellular or nonspecific mitogenic stimuli

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2011.574119

Role for interferon-gamma in the immunomodulatory activity of human bone marrow mesenchymal stem cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2011.574119

Suppression of allogeneic T-cell proliferation by human marrow stromal cells: implications in transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2011.574119

Mesenchymal stem cells inhibit lymphocyte proliferation by mitogens and alloantigens by different mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2011.574119

Bone marrow mesenchymal stem cells inhibit the response of naive and memory antigen-specific T cells to their cognate peptide.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2011.574119

Human mesenchymal stem cells modulate B-cell functions

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2011.574119

Mesenchymal stem cells suppress B-cell terminal differentiation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2011.574119

Mesenchymal stem cells stimulate antibody secretion in human B cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2011.574119

Bone marrow-derived mesenchymal stem cells induce both polyclonal expansion and differentiation of B cells isolated from healthy donors and systemic lupus erythematosus patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2011.574119

Effects of mesenchymal stem cells on differentiation, maturation, and function of human monocyte-derived dendritic cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2011.574119

Human mesenchymal stem cells alter antigen-presenting cell maturation and induce T-cell unresponsiveness

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2011.574119

Human bone marrow stromal cells inhibit allogeneic T-cell responses by indoleamine 2,3-dioxygenase-mediated tryptophan degradation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2011.574119

Inflammation in wound repair: molecular and cellular mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2011.574119

Inflammation and tumor microenvironments: defining the migratory itinerary of mesenchymal stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2011.574119

Functional expression of HGF and HGF receptor/c-met in adult human mesenchymal stem cells suggests a role in cell mobilization, tissue repair, and wound healing.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2011.574119

Mesenchymal stem cells transmigrate over the endothelial barrier

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2011.574119

Mesenchymal stem cell engraftment in lung is enhanced in response to bleomycin exposure and ameliorates its fibrotic effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2011.574119

Therapeutic benefit of intravenous administration of bone marrow stromal cells after cerebral ischemia in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2011.574119

Marrow stromal cells form guiding strands in the injured spinal cord and promote recovery

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2011.574119

Tumors: wounds that do not heal. Similarities between tumor stroma generation and wound healing

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2011.574119

Direct evidence of mesenchymal stem cell tropism for tumor and wounding microenvironments using in vivo bioluminescent imaging

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2011.574119

Antitumor effect of genetically engineered mesenchymal stem cells in a rat glioma model

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2011.574119

Cancer gene therapy using mesenchymal stem cells expressing interferon-beta in a mouse prostate cancer lung metastasis model

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2011.574119

Therapeutic potential of mesenchymal stem cells producing interferon-alpha in a mouse melanoma lung metastasis model

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2011.574119

Mesenchymal stem cells derived from bone marrow favor tumor cell growth in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2011.574119

Mesenchymal stem cells share molecular signature with mesenchymal tumor cells and favor early tumor growth in syngeneic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2011.574119

Cardiomyocyte transfer into the mammalian heart. Cell-to-cell interactions in vivo and in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2011.574119

Skeletal myoblast transplantation for repair of myocardial necrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2011.574119

Electrophysiological effects of intracoronary transplantation of autologous mesenchymal and endothelial progenitor cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2011.574119

A randomized, double-blind, placebo-controlled, dose-escalation study of intravenous adult human mesenchymal stem cells (prochymal) after acute myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2011.574119

Intra-coronary arterial injection of mesenchymal stromal cells and microinfarction in dogs.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2011.574119

Potential risks of bone marrow cell transplantation into infarcted hearts.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2011.574119

Transplantation of hypoxia-preconditioned mesenchymal stem cells improves infarcted heart function via enhanced survival of implanted cells and angiogenesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2011.574119

Short-term exposure of multipotent stromal cells to low oxygen increases their expression of CX3CR1 and CXCR4 and their engraftment in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2011.574119

Pre-treatment of mesenchymal stem cells with a combination of growth factors enhances gap junction formation, cytoprotective effect on cardiomyocytes, and therapeutic efficacy for myocardial infarction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2011.574119

Strategies to promote donor cell survival: combining preconditioning approach with stem cell transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2011.574119

Combined therapy with simvastatin and bone marrow-derived mesenchymal stem cells increases benefits in infarcted swine hearts

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2011.574119

A long-term follow-up study of intravenous autologous mesenchymal stem cell transplantation in patients with ischemic stroke

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2011.574119

Autologous mesenchymal stem cell therapy delays the progression of neurological deficits in patients with multiple system atrophy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2011.574119

Ex vivo-expanded autologous bone marrow-derived mesenchymal stromal cells in human spinal cord injury/paraplegia: a pilot clinical study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2011.574119

Autologous mesenchymal stem cells: clinical applications in amyotrophic lateral sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2011.574119

Allogeneic mesenchymal stem cell infusion for treatment of metachromatic leukodystrophy (MLD) and Hurler syndrome (MPS-IH).

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2011.574119

Open-labeled study of unilateral autologous bone-marrow-derived mesenchymal stem cell transplantation in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2011.574119

Therapeutic potential of bone marrow-derived mesenchymal stem cells on experimental liver fibrosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2011.574119

The therapeutic potential of human umbilical mesenchymal stem cells from Wharton's jelly in the treatment of rat liver fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2011.574119

Molecular mechanism of hepatic stellate cell activation and antifibrotic therapeutic strategies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2011.574119

Improvement of liver function in liver cirrhosis patients after autologous mesenchymal stem cell injection: a phase I-II clinical trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2011.574119

Phase 1 human trial of autologous bone marrow-hematopoietic stem cell transplantation in patients with decompensated cirrhosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2011.574119

Mesenchymal stem cells are renotropic, helping to repair the kidney and improve function in acute renal failure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2011.574119

Administered mesenchymal stem cells protect against ischemic acute renal failure through differentiation-independent mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2011.574119

Acute renal failure outcomes in children and adults.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2011.574119

Bone marrow-derived mesenchymal stem cells ameliorate autoimmune enteropathy independently of regulatory T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2011.574119

Mesenchymal stem cells ameliorate experimental autoimmune encephalomyelitis inducing T-cell anergy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2011.574119

Immunomodulatory function of bone marrow-derived mesenchymal stem cells in experimental autoimmune type 1 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2011.574119

Mesenchymal stem cell transplantation reverses multiorgan dysfunction in systemic lupus erythematosus mice and humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2011.574119

Bone marrow mesenchymal stromal cells (BM-MSCs) from healthy donors and auto-immune disease patients reduce the proliferation of autologous- and allogeneic-stimulated lymphocytes in vitro.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2011.574119

Autologous bone marrow-derived mesenchymal stromal cell treatment for refractory luminal Crohn's disease: results of a phase I study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2011.574119

Susceptibility of human mesenchymal stem cells to tacrolimus, mycophenolic acid, and rapamycin

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2011.574119

Human mesenchymal stem cells and immunosuppressive drug interactions in allogeneic responses: an in vitro study using human cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2011.574119

Mesenchymal stem cell and immunosuppressive drug interactions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2011.574119

Human adipose tissue-derived mesenchymal stem cells facilitate the immunosuppressive effect of cyclosporin A on T lymphocytes through Jagged-1-mediated inhibition of NF-κB signaling.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2011.574119

Treatment of deep cartilage defects in the knee with autologous chondrocyte transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2011.574119

The Clinical Use of Human Culture-Expanded Autologous Bone Marrow Mesenchymal Stem Cells Transplanted on Platelet-Rich Fibrin Glue in the Treatment of Articular Cartilage Defects: A Pilot Study and Preliminary Results

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2011.574119

Transplantability and therapeutic effects of bone marrow-derived mesenchymal cells in children with osteogenesis imperfecta

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2011.574119

Autologous bone marrow stromal cell transplantation for repair of full-thickness articular cartilage defects in human patellae: two case reports.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2011.574119

Role of morphogenetic proteins in skeletal tissue engineering and regeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2011.574119

Adult mesenchymal stem cells and cell-based tissue engineering

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2011.574119

Therapeutic potential of mesenchymal stem cells for severe acute lung injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2011.574119

Mesenchymal stem cells attenuate hypoxic pulmonary vasoconstriction by a paracrine mechanism.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2011.574119

Investigation of bone marrow mesenchymal stem cells (BM MSCs) involvement in Idiopathic Pulmonary Fibrosis (IPF).

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2011.574119

Autologous bone marrow-derived cultured mesenchymal stem cells delivered in a fibrin spray accelerate healing in murine and human cutaneous wounds.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2011.574119

Combination stem cell therapy for the treatment of severe limb ischemia: safety and efficacy analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2011.574119

Potentiality of mesenchymal stem cells in regeneration of sweat glands

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2011.574119

New approach to radiation burn treatment by dosimetry-guided surgery combined with autologous mesenchymal stem cell therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2011.574119

Expanded adipose-derived stem cells for the treatment of complex perianal fistula: a phase II clinical trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2011.574119

Mesenchymal stem cells for treatment of steroid-resistant, severe, acute graft-versus-host disease: a phase II study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2011.574119

Infusion of mesenchymal stromal cells can aid hematopoietic recovery following allogeneic hematopoietic stem cell myeloablative transplant: a pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2011.574119

How I treat refractory acute GVHD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2011.574119

Favorable response to human adipose tissue-derived mesenchymal stem cells in steroid-refractory acute graft-versus-host disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2011.574119

Mesenchymal stem cell as salvage treatment for refractory chronic GVHD

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2011.574119

Mesenchymal stem cells suppress lymphocyte proliferation in vitro and prolong skin graft survival in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2011.574119

Mesenchymal stem cells prevent the rejection of fully allogenic islet grafts by the immunosuppressive activity of matrix metalloproteinase-2 and -9

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2011.574119

Human adipose tissue is a source of multipotent stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2011.574119

Aging is associated with decreased maximal life span and accelerated senescence of bone marrow stromal cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2011.574119

Novel sources of fetal stem cells: where do they fit on the developmental continuum?

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2011.574119

The immunomodulatory activity of human umbilical cord blood-derived mesenchymal stem cells in vitro.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2011.574119

Fetal mesenchymal stem cells derived from human umbilical cord sustain primitive characteristics during extensive expansion

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2011.574119

Molecular and proteomic characterization of human mesenchymal stem cells derived from amniotic fluid: comparison to bone marrow mesenchymal stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2011.574119

Comparative analysis of mesenchymal stem cells from bone marrow, umbilical cord blood, or adipose tissue

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2011.574119

Functional network analysis of the transcriptomes of mesenchymal stem cells derived from amniotic fluid, amniotic membrane, cord blood, and bone marrow.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2011.574119

Replicative senescence-associated gene expression changes in mesenchymal stromal cells are similar under different culture conditions

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2011.574119

Proliferation kinetics and differentiation potential of ex vivo expanded human bone marrow stromal cells: Implications for their use in cell therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2011.574119

Replicative senescence of mesenchymal stem cells: a continuous and organized process

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2011.574119

Human mesenchymal stem cells self-renew and differentiate according to a deterministic hierarchy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2011.574119

Mesenchymal stem cell homing: the devil is in the details

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2011.574119

Dual-modality monitoring of targeted intraarterial delivery of mesenchymal stem cells after transient ischemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2011.574119

Human cord blood cells and myocardial infarction: effect of dose and route of administration on infarct size.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2011.574119

Therapeutic window for treatment of cortical ischemia with bone marrow-derived cells in rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2011.574119

Therapeutic time window of mesenchymal stem cells derived from bone marrow after cerebral ischemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2011.574119

Age- and dose-related effects on MSC engraftment levels and anatomical distribution in the central nervous systems of nonhuman primates: identification of novel MSC subpopulations that respond to guidance cues in brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2011.574119

High inoculation cell density could accelerate the differentiation of human bone marrow mesenchymal stem cells to chondrocyte cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2011.574119

Cell isolation procedures matter: a comparison of different isolation protocols of bone marrow mononuclear cells used for cell therapy in patients with acute myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2011.574119

A transformed cell population derived from cultured mesenchymal stem cells has no functional effect after transplantation into the injured heart

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2011.574119

A role for heme oxygenase-1 in the immunosuppressive effect of adult rat and human mesenchymal stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2011.574119

Migration of Bone Marrow and Cord Blood Mesenchymal Stem Cells In Vitro Is Regulated by Stromal-Derived Factor-1-CXCR4 and Hepatocyte Growth Factor-c-met Axes and Involves Matrix Metalloproteinases

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2011.574119

Mesenchymal stem cell adhesion to cardiac microvascular endothelium: activators and mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2011.574119

Pretransplant Infusion of Mesenchymal Stem Cells Prolongs the Survival of a Semiallogeneic Heart Transplant through the Generation of Regulatory T Cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2011.574119

FDA challenges stem-cell clinic

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2011.574119

10.1517/14712598.2011.574119

21 January 2018

Identifiers

DOI

1 reference

24 August 2017

1 reference